Home » Stocks » ATRX

Adhera Therapeutics, Inc. (ATRX)

Stock Price: $0.0790 USD 0.0090 (12.86%)
Updated November 25, 3:49 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 858,691
Revenue (ttm) 132,000
Net Income (ttm) -8.89M
Shares Out 10.87M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 25
Last Price $0.0790
Previous Close $0.0700
Change ($) 0.0090
Change (%) 12.86%
Day's Open 0.0635
Day's Range 0.0480 - 0.0790
Day's Volume 10,660
52-Week Range 0.02 - 0.14

More Stats

Market Cap 858,691
Enterprise Value 7.11M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 10.87M
Float 7.95M
EPS (basic) -0.82
EPS (diluted) -0.82
FCF / Share -0.28
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 40,932
Short Ratio 3.24
Short % of Float 0.52%
Beta 1.09
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.51
PB Ratio n/a
Revenue 132,000
Operating Income -5.63M
Net Income -8.89M
Free Cash Flow -3.04M
Net Cash -6.25M
Net Cash / Share -0.58
Gross Margin -118.94%
Operating Margin -4,263.64%
Profit Margin -6,737.10%
FCF Margin -2,303.03%
ROA -134.61%
ROE n/a
ROIC 93.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$400.00*
Low
400
Current: $0.0790
High
400
Target: 400.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.250.08---0.502.124.222.242.46
Revenue Growth231.58%-----76.36%-49.85%88.6%-9.11%-
Gross Profit-0.16-0.21---0.502.124.222.242.46
Operating Income-11.32-15.80-6.09-0.76-1.11-3.52-0.37-7.88-35.00-29.53
Net Income-11.98-16.76-6.22-0.84-1.11-6.48-1.57-9.55-29.42-27.75
Shares Outstanding10.8410.849.8447.430.292.461.691.340.630.18
Earnings Per Share-1.24-1.64-0.63-0.02-3.80-5.10-0.90-7.10-46.50-158.00
Operating Cash Flow-8.74-9.61-1.26-0.52-0.74-4.780.29-4.39-16.12-16.80
Capital Expenditures--0.07----0.030.43--0.40
Free Cash Flow-8.74-9.69-1.26-0.52-0.74-4.780.32-3.96-16.12-17.21
Cash & Equivalents0.053.920.110.110.261.820.910.601.992.08
Total Debt5.33-1.910.69--1.621.45--
Net Cash / Debt-5.283.92-1.80-0.580.261.82-0.71-0.851.992.08
Assets0.425.146.186.190.269.227.747.4511.7529.44
Liabilities10.312.215.742.970.1713.5914.8113.0811.7112.27
Book Value-9.892.930.453.220.09-4.37-7.06-5.630.0417.17
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Adhera Therapeutics, Inc.
Country United States
Employees 2
CEO Andrew Albert Kucharchuk

Stock Information

Ticker Symbol ATRX
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: ATRX

Description

Adhera Therapeutics does not have significant operations. Previously, it was involved in the development and commercialization of drug therapeutics for chronic and acute diseases in the United States. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is headquartered in Wake Forest, North Carolina.